W13--Epidemiology in Action: Insights from CF Registries & Beyond
W13.4- Long term causal effects of ivacaftor on airway microbiology and lung function outcomes in people with cystic fibrosis: An emulation of target trials with the U.S. CF Foundation Patient Registry data
